Filing Details
- Accession Number:
- 0000200406-25-000172
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-18 16:12:41
- Reporting Period:
- 2025-07-17
- Filing Date:
- 2025-07-18
- Accepted Time:
- 2025-07-18 16:12:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
200406 | Johnson & Johnson | JNJ | Pharmaceutical Preparations (2834) | 221024240 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1181561 | C John Reed | One Johnson &Amp; Johnson Plaza New Brunswick NJ 08933 | Evp, Innovative Medicine, R&D | No | Yes | No | No |
Transaction Summary
Sold: | 19,137 shares | Avg. Price: $163.55 | Total Value: $3,129,829.56 |
Number of Shares After Transactions: | 10,658 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-07-17 | 19,137 | $163.55 | 10,658 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $163.52 to $163.61. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.